NCT07708272 clinical trial report covering Rovadicitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07708038 clinical trial report covering Tocilizumab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262765 clinical trial report covering YP004, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262758 clinical trial report covering SY-12321, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262601 clinical trial report covering Obefazimod, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262763 clinical trial report covering Flunotinib maleate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07710768 clinical trial report covering UBT-251, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600128307 clinical trial report covering EP-0210, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262732 clinical trial report covering HBW-3220, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07711184 clinical trial report covering HRS-7525, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07710690 clinical trial report covering NRG-103, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07712393 clinical trial report covering SHR-1905, Phase 1, endpoints, sponsor, geography, readout timing and development white space.